Bristol-myers Squibb Co. share price logo

Bristol-myers Squibb Co. Share Price

NYSE: BMY

Large Cap

$43.81

+0.27

(+0.62%)

as on

Bristol-myers Squibb Co. Stock Performance

as on October 15, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $43.27
    $43.9
    downward going graph

    1.23%

    Downside

    0.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $42.96
    $63.33
    downward going graph

    1.94%

    Downside

    44.56%

    Upside

    downward going graph

Bristol-myers Squibb Co. share price movements today

Previous Close
$43.54
Open
$43.39
Volume
16.2M
Day's Low - High
$43.27 - $43.9
52 Week Low - High
$42.96 - $63.33

Bristol-myers Squibb Co. Historical Returns

1 Month Return
-5.5 %
3 Month Return
-5.66 %
1 Year Return
-16.98 %
3 Year Return
-37.98 %
5 Year Return
-27.51 %

Bristol-myers Squibb Co. Stock Fundamentals & Key Indicators

Check Bristol-myers Squibb Co. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$89.2B

EPS (TTM)

6.4495

Dividend Yield

4.67%

Quarterly Earnings Growth YOY

-0.23%

PE Ratio (TTM)

17.59

Industry PE ratio

19.200384615384614

PEG Ratio

2.2562

EBITDA

19.1B

Revenue (TTM)

47.7B

Profit Margin

10.58%

Return On Equity TTM

29.32%

Bristol-myers Squibb Co. Stock Valuation

Track how Bristol-myers Squibb Co. P/E has moved over time to understand its valuation trends.

Bristol-myers Squibb Co. in the last 5 years

  • Overview

  • Trends

Lowest (7.05x)

September 30, 2025

Today (17.59x)

October 15, 2025

Industry (19.20x)

October 15, 2025

Highest (54.19x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 17.59x

Bristol-myers Squibb Co. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bristol-myers Squibb Co. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Bristol-myers Squibb Co. image
Bristol-myers Squibb Co.
HOLD$89.2B-27.51%17.5910.58%
Eli Lilly And Company image
Eli Lilly And Company
BUY$734.6B453.45%53.225.91%
Abbvie Inc image
Abbvie Inc
BUY$406.8B168.84%109.676.45%
Johnson & Johnson image
Johnson & Johnson
BUY$459.8B29.66%20.4425.00%
Novo Nordisk A/s image
Novo Nordisk A/s
BUY$257.8B60.58%14.935.61%
See all

Stock Returns calculator for Bristol-myers Squibb Co. Stock including INR - Dollar returns

The Bristol-myers Squibb Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bristol-myers Squibb Co. investment value today

Current value as on today

₹88,804

Returns

₹11,196

(-11.2%)

Returns from Bristol-myers Squibb Co. Stock

₹16,964 (-16.96%)

Dollar Returns*

₹5,768 (+5.77%)

Analyst Recommendation on Bristol-myers Squibb Co. Stock

Based on 31 analysts

HOLD

32.26%

Buy

64.52%

Hold

3.23%

Sell

Based on 31 analysts, 64.52% of analysts recommend a 'HOLD' rating for Bristol-myers Squibb Co.. Average target price of $53.05

Bristol-myers Squibb Co. Share Price Target

Get share price movements and forecasts by analysts on Bristol-myers Squibb Co..

What analysts predicted

17.42%UPSIDE

Target Price

$53.05

Current Price

$43.81

Analyzed by

31 Analysts

Target

$53.05

Bristol-myers Squibb Co. target price $53.05, a slight upside of 17.42% compared to current price of $43.81. According to 31 analysts rating.

Bristol-myers Squibb Co. Stock’s Investor Sentiment and Interest

Investment in Bristol-myers Squibb Co. Shares on INDmoney has grown by 165.90% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:165.90% versus previous 30 day period

Search interest for Bristol-myers Squibb Co. Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:34% versus previous 30 day period

Bristol-myers Squibb Co. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
11,337
11,226
10,966
11,477
11,865
12,201
11,892
12,342
11,201
12,269
Gross Profit
6,516
6,129
6,220
6,492
6,590
6,801
6,617
7,424
7,340
8,070
Operating Income
2,453
1,943
2,104
1,952
1,535
2,584
2,288
2,531
3,521
4,117
EBITDA
5,487
4,573
4,852
4,454
-8,559
4,403
4,773
2,551
4,477
3,287
Interest Expense
288
282
280
316
425
521
505
496
494
485
Depreciation
2,256
2,257
2,435
2,464
2,532
2,596
2,592
1,880
1,012
1,011
Income Before Tax
2,770
1,859
2,137
1,674
-11,516
1,286
1,676
175
2,971
1,773
Income Tax Expense
503
-218
203
-88
392
-398
461
99
509
460
Net Income
2,262
2,073
1,928
1,762
-11,911
1,680
1,211
72
2,456
1,310
Net Profit Margin
19.95%
18.47%
17.58%
15.35%
-100.39%
13.77%
10.18%
0.58%
21.93%
10.68%

Bristol-myers Squibb Co. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
16,560
19,427
20,776
22,561
26,145
42,518
46,385
46,159
45,006
48,300
Gross Profit
12,806
14,495
14,958
16,075
17,250
21,700
26,761
26,490
25,357
27,432
Operating Income
3,938
5,179
5,239
6,394
6,439
4,492
9,540
9,271
8,472
9,658
EBITDA
2,637
6,464
6,116
6,788
7,377
4,929
20,118
19,221
19,366
3,168
Interest Expense
184
167
196
183
656
1,420
1,334
1,232
1,166
1,947
Depreciation
-
-
789
637
1,746
10,380
10,023
9,595
9,817
9,600
Income Before Tax
2,077
5,915
5,131
5,968
4,975
-6,871
8,098
7,713
8,440
-8,379
Income Tax Expense
446
1,408
4,156
1,021
1,515
2,124
1,084
1,368
400
554
Net Income
1,565
4,457
1,007
4,920
3,439
-8,995
6,994
6,327
8,025
-8,948
Net Profit Margin
9.45%
22.94%
4.85%
21.81%
13.15%
-21.16%
15.08%
13.71%
17.83%
-18.53%

Bristol-myers Squibb Co. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
2,077
1,934
1,762
-11,908
1,684
1,215
76
2,462
1,313
Operating Cash Flow
1,887
4,751
4,252
2,834
2,326
5,591
4,439
1,954
3,917
Investing Cash Flow
-329
-410
-1,346
-19,618
-1,319
-219
-196
-499
-473
Financing Cash Flow
-2,173
-5,160
967
14,644
-4,023
-3,852
-1,642
-993
-1,836
Change in Cash
-623
-857
3,951
-2,185
-3,038
1,597
2,454
528
1,736

Bristol-myers Squibb Co. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
4,507
975
4,947
3,460
-8,995
7,014
6,345
8,040
-8,933
Operating Cash Flow
3,058
5,275
7,066
8,067
14,052
16,207
13,066
13,860
15,190
Investing Cash Flow
1,480
-66
-2,000
-9,770
-10,859
-538
-1,062
-2,295
-21,352
Financing Cash Flow
-2,653
-4,077
-3,535
7,621
-1,151
-16,224
-16,962
-9,416
5,127
Change in Cash
1,852
1,184
1,490
5,909
2,153
-657
-4,991
2,194
-1,172

Mutual Funds that own Bristol-myers Squibb Co. Stock

Check out the Mutual Funds with significant holdings in Bristol-myers Squibb Co..

Global Institutional Holdings in Bristol-myers Squibb Co.

Funds
Holdings
Vanguard Group Inc
9.58%
BlackRock Inc
8.46%
JPMorgan Chase & Co
5.11%
State Street Corp
4.65%
Charles Schwab Investment Management Inc
3.48%
See all

Bristol-myers Squibb Co. News & Key Events

  • img

    Today's Timeline - 10 October

    Fri, 08:42 PM

    -

    Bristol Myers Squibb to acquire Orbital Therapeutics for $1.5 billion, enhancing its CAR T-cell immunotherapy portfolio.

Insights on Bristol-myers Squibb Co.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Bristol-Myers Squibb Co. has shown positive revenue growth over the last two quarters. The revenue increased from $11.20 billion to $12.26 billion, reflecting an average increase of 8.7% per quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly And Company has given 60.3% return, outperforming this stock by 98.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Abbvie Inc has given 19.4% return, outperforming this stock by 36.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Bristol-Myers Squibb Co. has experienced a decline in net profit over the past two quarters. The net profit dropped significantly from $2.45 billion to $1.31 billion, averaging a decrease of 46.7% each quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, BMY stock has moved down by -12.4%

About Bristol-myers Squibb Co.

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
OrganisationBristol-myers Squibb Co.
HeadquartersRoute 206 & Province Line Road, Princeton, NJ, United States, 08543
IndustryHealth Technology
CEODr. Christopher S. Boerner Ph.D.
E-voting on sharesClick here to vote

Key Management of Bristol-myers Squibb Co.

Name

Title

Dr. Christopher S. Boerner Ph.D.

CEO & Chairman

Mr. David V. Elkins

Executive VP & CFO

Ms. Karin Shanahan

Executive VP, Chief Supply Chain & Operations Officer

Mr. Samit Hirawat M.D.

Advisor

Ms. Kimberly M. Jablonski

Chief Compliance & Ethics Officer

Mr. Greg Meyers

Executive VP and Chief Digital & Technology Officer

Ms. Cari Gallman

Executive Vice President, General Counsel & Chief Policy Officer

Ms. Ahn Amanda Poole

Executive VP & Chief People Officer

Dr. Joseph J. Eiden Jr.

Head of Medical Affairs

Mr. Adam Lenkowsky

Executive VP & Chief Commercialization Officer

FAQs

What is Bristol-myers Squibb Co. share price today?

Bristol-myers Squibb Co. share price today is $43.81 as on at the close of the market. Bristol-myers Squibb Co. share today touched a day high of $43.9 and a low of $43.27.

What is the 52 week high and 52 week low for Bristol-myers Squibb Co. share?

Bristol-myers Squibb Co. share touched a 52 week high of $63.33 on and a 52 week low of $42.96 on . Bristol-myers Squibb Co. stock price today i.e. is closed at $43.81,which is 30.82% down from its 52 week high and 1.98% up from its 52 week low.

What is Bristol-myers Squibb Co.'s market capitalisation today?

Bristol-myers Squibb Co. market capitalisation is $0.09T as on .

How to invest in Bristol-myers Squibb Co. Stock (BMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bristol-myers Squibb Co. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bristol-myers Squibb Co. Shares that will get you 0.0342 shares as per Bristol-myers Squibb Co. share price of $43.81 per share as on October 15, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bristol-myers Squibb Co. Stock (BMY) from India?

Indian investors can start investing in Bristol-myers Squibb Co. (BMY) shares with as little as ₹88.771 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.71 in Bristol-myers Squibb Co. stock (as per the Rupee-Dollar exchange rate as on ). Based on Bristol-myers Squibb Co. share’s latest price of $43.81 as on October 15, 2025 at 1:29 am IST, you will get 0.2283 shares of Bristol-myers Squibb Co.. Learn more about fractional shares .

What are the returns that Bristol-myers Squibb Co. has given to Indian investors in the last 5 years?

Bristol-myers Squibb Co. stock has given -27.51% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?